$159.00
630 in stock
The Triple Peptide Research Kit combines three synthetic research peptides — TB-500 (Thymosin Beta-4), BPC-157 (Body Protection Compound-157), and GHK-Cu (Glycine-Histidine-Lysine Copper) — each classified within distinct peptide families and studied extensively in laboratory settings for their interactions with cellular signaling pathways. This kit has been developed to support research environments requiring simultaneous access to three independently documented research compounds within a single procurement.
In research environments, TB-500, BPC-157, and GHK-Cu are frequently studied in relation to cellular regulatory signaling, peptide receptor interactions, and pathway mechanisms associated with tissue-level and extracellular matrix cellular communication. Each compound represents a separate and distinct area of peptide research with independently documented laboratory investigation histories spanning multiple decades of preclinical scientific literature.
Scientists have explored the receptor binding characteristics, signaling behavior, and extracellular interaction profiles of all three compounds within controlled experimental models, examining how each peptide interacts with its respective biological pathways in laboratory research settings.
Research Applications
This triple compound research kit has been examined across several areas of laboratory research, including:
These research applications focus on understanding how synthetic peptides from three distinct classification families interact with receptor systems and extracellular signaling networks involved in cellular regulatory pathways.
Mechanism and Pathway Context
Research has investigated TB-500 for its interaction with actin-binding pathways, a cellular mechanism involved in cytoskeletal organization and peptide mediated cellular signaling. Studies have explored how this thymosin peptide interacts with G-actin sequestration mechanisms and how this interaction influences downstream signaling cascades involved in cytoskeletal regulatory pathway activity in laboratory models.
Research has investigated BPC-157 for its interaction with growth factor signaling pathways, including those associated with vascular endothelial and fibroblast growth factor receptor systems in preclinical laboratory models. Studies have explored how this synthetic pentadecapeptide interacts with receptor specific signaling mechanisms that influence cellular communication pathways and growth factor receptor cascades in experimental research settings.
Research has investigated GHK-Cu for its interaction with extracellular matrix signaling pathways and copper-dependent cellular regulatory mechanisms studied in laboratory models. Studies have explored how this tripeptide copper complex interacts with cellular signaling systems associated with extracellular matrix remodeling research, fibroblast signaling pathway investigations, and gene expression regulatory mechanisms in controlled experimental settings.
Laboratory investigations also examine how peptides from distinct structural classifications interact with overlapping and divergent cellular signaling networks, providing researchers with comparative data across multiple peptide compound classes within a single research protocol.
Research Summary
TB-500 was identified as part of broader research into thymosin family peptides and their interaction with actin-binding mechanisms in cellular systems. Early peptide research explored synthetic thymosin derivatives capable of interacting with cytoskeletal regulatory pathways while maintaining structural stability in laboratory conditions. Scientific investigations have examined its biochemical characteristics, actin sequestration activity, and signaling interactions within cytoskeletal pathway research models.
BPC-157 was developed as part of ongoing research into gastric pentadecapeptides and their interaction with growth factor receptor signaling systems. Early investigations explored synthetic peptides derived from gastric protein sequences for their receptor interaction profiles and signaling characteristics in preclinical laboratory models. Scientific investigations have examined its biochemical characteristics, receptor binding activity, and growth factor signaling interactions within cellular pathway research models.
GHK-Cu was first identified during research into copper-binding tripeptides and their interaction with extracellular matrix regulatory mechanisms in laboratory settings. Early research explored the copper chelating properties of this tripeptide complex and its documented interactions with fibroblast signaling systems and extracellular matrix associated gene expression pathways in experimental models. Scientific investigations have examined its biochemical characteristics, copper coordination chemistry, and cellular signaling interactions within extracellular matrix pathway research.
Current research continues to explore how peptides in these respective classes interact with receptor mediated signaling systems and cellular regulatory pathways, with all three compounds representing well-documented subjects of ongoing preclinical laboratory investigation.
Product Specifications
TB-500 (Thymosin Beta-4)
BPC-157 (Body Protection Compound-157)
GHK-Cu (Glycine-Histidine-Lysine Copper)
Storage and Handling
All three compounds in this kit are supplied as lyophilized research peptide powders. For laboratory stability purposes, storage under refrigerated conditions is recommended for each compound following reconstitution. Proper laboratory handling procedures should be followed to maintain compound integrity for all three peptides during research applications.
Research Use Disclaimer
FOR RESEARCH USE ONLY. This product is intended strictly for laboratory research purposes. It is not intended for human or veterinary use.
Scientific Background
TB-500 belongs to the thymosin family of peptides, a class of naturally occurring signaling molecules first identified in thymic tissue research. Thymosin Beta-4 was isolated and characterized as part of broader investigations into peptide based cellular signaling compounds involved in cytoskeletal regulatory mechanisms. Researchers have explored its biochemical structure and actin-binding characteristics within controlled laboratory models focused on cytoskeletal organization and cellular signaling systems. Its interaction with G-actin sequestration pathways makes it a compound of ongoing interest in synthetic peptide signaling research.
BPC-157 belongs to the class of synthetic pentadecapeptides derived from sequences identified in gastric protein research. It was developed during investigations into peptide compounds capable of interacting with growth factor receptor signaling systems in laboratory models. Researchers have explored its biochemical structure and receptor binding characteristics within controlled laboratory models focused on vascular and fibroblast growth factor signaling pathways. Its structure as a fifteen amino acid synthetic peptide allows scientists to examine peptide receptor interaction dynamics and signaling specificity within growth factor related research pathways.
GHK-Cu belongs to the class of copper-binding tripeptide complexes first identified during research into plasma-derived peptide signaling compounds. The glycine-histidine-lysine sequence was characterized as part of broader investigations into copper coordination chemistry and its relationship to extracellular matrix associated cellular signaling in laboratory models. Researchers have explored its biochemical structure, copper chelation characteristics, and interaction with fibroblast signaling systems within controlled laboratory models focused on extracellular matrix regulatory pathways. Its tripeptide copper complex structure makes it a compound of ongoing interest in extracellular matrix and gene expression signaling research.
The Triple Peptide Research Kit provides research environments with simultaneous access to three independently documented research compounds from distinct peptide classification families, supporting laboratory protocols that require comparative or parallel investigation of multiple peptide signaling systems across cytoskeletal, growth factor receptor, and extracellular matrix research pathways.
Key Research Areas
Cytoskeletal Signaling Research — TB-500 Laboratory studies have explored TB-500 as a model compound for examining actin-binding mechanisms and cytoskeletal regulatory signaling pathways in controlled experimental models. These investigations help researchers understand how synthetic thymosin peptides interact with G-actin sequestration systems and downstream cytoskeletal signaling networks.
Growth Factor Receptor Signaling Research — BPC-157 Research has examined how BPC-157 interacts with growth factor receptor signaling systems and how this interaction influences receptor activation and intracellular signaling cascades in experimental models. These investigations help researchers understand how synthetic pentadecapeptides interact with vascular and fibroblast growth factor receptor pathways in preclinical laboratory settings.
Extracellular Matrix Signaling Research — GHK-Cu Laboratory studies have explored GHK-Cu as a model compound for examining copper-dependent extracellular matrix signaling pathways and fibroblast associated cellular regulatory mechanisms in controlled research models. These investigations help researchers understand how synthetic copper tripeptide complexes interact with extracellular matrix associated gene expression and cellular signaling systems.
Comparative Multi-Peptide Pathway Research — All Three Compounds Experimental models have explored how peptides from thymosin, pentadecapeptide, and copper tripeptide classification families interact with overlapping and divergent cellular signaling networks in laboratory research settings. These investigations support comparative research into how structurally distinct synthetic peptides from three independent classification families interact with cytoskeletal, growth factor receptor, and extracellular matrix regulatory signaling systems.
Pathway Interaction Overview
Research has examined TB-500 for its interaction with actin-binding pathways involved in cytoskeletal organization, BPC-157 for its interaction with growth factor receptor systems involved in vascular and fibroblast signaling pathways, and GHK-Cu for its interaction with extracellular matrix signaling mechanisms and copper-dependent cellular regulatory pathways in laboratory research models.
Laboratory studies investigate how receptor binding and extracellular interactions for each compound independently influence intracellular signaling mechanisms, including cytoskeletal communication systems for TB-500, growth factor receptor cascades for BPC-157, and extracellular matrix associated gene expression regulatory pathways for GHK-Cu in controlled research settings.
Scientists analyze how pathway activation for each respective compound may influence downstream signaling interactions that regulate cellular activity within their independently documented research pathway contexts, providing researchers with comparative data across three distinct areas of synthetic peptide signaling research.
Literature Overview
Scientific literature surrounding TB-500, BPC-157, and GHK-Cu addresses three distinct areas of peptide receptor interaction and extracellular signaling research, with each compound independently documented across preclinical laboratory investigations spanning multiple decades of published scientific literature.
Key themes explored in laboratory research include:
These investigations help expand scientific understanding of how synthetic peptides from distinct classification families interact with receptor mediated and extracellular signaling systems across multiple cellular regulatory pathway contexts.
References
TB-500 (Thymosin Beta-4)
BPC-157 (Body Protection Compound-157)
GHK-Cu (Glycine-Histidine-Lysine Copper)
Researchers interested in the biochemical and signaling characteristics of TB-500, BPC-157, and GHK-Cu are encouraged to review peer reviewed publications within these scientific databases.
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.
The Triple Peptide Research Kit combines three synthetic research peptides — TB-500 (Thymosin Beta-4), BPC-157 (Body Protection Compound-157), and GHK-Cu (Glycine-Histidine-Lysine Copper) — each classified within distinct peptide families and studied extensively in laboratory settings for their interactions with cellular signaling pathways. This kit has been developed to support research environments requiring simultaneous access to three independently documented research compounds within a single procurement.
In research environments, TB-500, BPC-157, and GHK-Cu are frequently studied in relation to cellular regulatory signaling, peptide receptor interactions, and pathway mechanisms associated with tissue-level and extracellular matrix cellular communication. Each compound represents a separate and distinct area of peptide research with independently documented laboratory investigation histories spanning multiple decades of preclinical scientific literature.
Scientists have explored the receptor binding characteristics, signaling behavior, and extracellular interaction profiles of all three compounds within controlled experimental models, examining how each peptide interacts with its respective biological pathways in laboratory research settings.
Research Applications
This triple compound research kit has been examined across several areas of laboratory research, including:
These research applications focus on understanding how synthetic peptides from three distinct classification families interact with receptor systems and extracellular signaling networks involved in cellular regulatory pathways.
Mechanism and Pathway Context
Research has investigated TB-500 for its interaction with actin-binding pathways, a cellular mechanism involved in cytoskeletal organization and peptide mediated cellular signaling. Studies have explored how this thymosin peptide interacts with G-actin sequestration mechanisms and how this interaction influences downstream signaling cascades involved in cytoskeletal regulatory pathway activity in laboratory models.
Research has investigated BPC-157 for its interaction with growth factor signaling pathways, including those associated with vascular endothelial and fibroblast growth factor receptor systems in preclinical laboratory models. Studies have explored how this synthetic pentadecapeptide interacts with receptor specific signaling mechanisms that influence cellular communication pathways and growth factor receptor cascades in experimental research settings.
Research has investigated GHK-Cu for its interaction with extracellular matrix signaling pathways and copper-dependent cellular regulatory mechanisms studied in laboratory models. Studies have explored how this tripeptide copper complex interacts with cellular signaling systems associated with extracellular matrix remodeling research, fibroblast signaling pathway investigations, and gene expression regulatory mechanisms in controlled experimental settings.
Laboratory investigations also examine how peptides from distinct structural classifications interact with overlapping and divergent cellular signaling networks, providing researchers with comparative data across multiple peptide compound classes within a single research protocol.
Research Summary
TB-500 was identified as part of broader research into thymosin family peptides and their interaction with actin-binding mechanisms in cellular systems. Early peptide research explored synthetic thymosin derivatives capable of interacting with cytoskeletal regulatory pathways while maintaining structural stability in laboratory conditions. Scientific investigations have examined its biochemical characteristics, actin sequestration activity, and signaling interactions within cytoskeletal pathway research models.
BPC-157 was developed as part of ongoing research into gastric pentadecapeptides and their interaction with growth factor receptor signaling systems. Early investigations explored synthetic peptides derived from gastric protein sequences for their receptor interaction profiles and signaling characteristics in preclinical laboratory models. Scientific investigations have examined its biochemical characteristics, receptor binding activity, and growth factor signaling interactions within cellular pathway research models.
GHK-Cu was first identified during research into copper-binding tripeptides and their interaction with extracellular matrix regulatory mechanisms in laboratory settings. Early research explored the copper chelating properties of this tripeptide complex and its documented interactions with fibroblast signaling systems and extracellular matrix associated gene expression pathways in experimental models. Scientific investigations have examined its biochemical characteristics, copper coordination chemistry, and cellular signaling interactions within extracellular matrix pathway research.
Current research continues to explore how peptides in these respective classes interact with receptor mediated signaling systems and cellular regulatory pathways, with all three compounds representing well-documented subjects of ongoing preclinical laboratory investigation.
Product Specifications
TB-500 (Thymosin Beta-4)
BPC-157 (Body Protection Compound-157)
GHK-Cu (Glycine-Histidine-Lysine Copper)
Storage and Handling
All three compounds in this kit are supplied as lyophilized research peptide powders. For laboratory stability purposes, storage under refrigerated conditions is recommended for each compound following reconstitution. Proper laboratory handling procedures should be followed to maintain compound integrity for all three peptides during research applications.
Research Use Disclaimer
FOR RESEARCH USE ONLY. This product is intended strictly for laboratory research purposes. It is not intended for human or veterinary use.
Scientific Background
TB-500 belongs to the thymosin family of peptides, a class of naturally occurring signaling molecules first identified in thymic tissue research. Thymosin Beta-4 was isolated and characterized as part of broader investigations into peptide based cellular signaling compounds involved in cytoskeletal regulatory mechanisms. Researchers have explored its biochemical structure and actin-binding characteristics within controlled laboratory models focused on cytoskeletal organization and cellular signaling systems. Its interaction with G-actin sequestration pathways makes it a compound of ongoing interest in synthetic peptide signaling research.
BPC-157 belongs to the class of synthetic pentadecapeptides derived from sequences identified in gastric protein research. It was developed during investigations into peptide compounds capable of interacting with growth factor receptor signaling systems in laboratory models. Researchers have explored its biochemical structure and receptor binding characteristics within controlled laboratory models focused on vascular and fibroblast growth factor signaling pathways. Its structure as a fifteen amino acid synthetic peptide allows scientists to examine peptide receptor interaction dynamics and signaling specificity within growth factor related research pathways.
GHK-Cu belongs to the class of copper-binding tripeptide complexes first identified during research into plasma-derived peptide signaling compounds. The glycine-histidine-lysine sequence was characterized as part of broader investigations into copper coordination chemistry and its relationship to extracellular matrix associated cellular signaling in laboratory models. Researchers have explored its biochemical structure, copper chelation characteristics, and interaction with fibroblast signaling systems within controlled laboratory models focused on extracellular matrix regulatory pathways. Its tripeptide copper complex structure makes it a compound of ongoing interest in extracellular matrix and gene expression signaling research.
The Triple Peptide Research Kit provides research environments with simultaneous access to three independently documented research compounds from distinct peptide classification families, supporting laboratory protocols that require comparative or parallel investigation of multiple peptide signaling systems across cytoskeletal, growth factor receptor, and extracellular matrix research pathways.
Key Research Areas
Cytoskeletal Signaling Research — TB-500 Laboratory studies have explored TB-500 as a model compound for examining actin-binding mechanisms and cytoskeletal regulatory signaling pathways in controlled experimental models. These investigations help researchers understand how synthetic thymosin peptides interact with G-actin sequestration systems and downstream cytoskeletal signaling networks.
Growth Factor Receptor Signaling Research — BPC-157 Research has examined how BPC-157 interacts with growth factor receptor signaling systems and how this interaction influences receptor activation and intracellular signaling cascades in experimental models. These investigations help researchers understand how synthetic pentadecapeptides interact with vascular and fibroblast growth factor receptor pathways in preclinical laboratory settings.
Extracellular Matrix Signaling Research — GHK-Cu Laboratory studies have explored GHK-Cu as a model compound for examining copper-dependent extracellular matrix signaling pathways and fibroblast associated cellular regulatory mechanisms in controlled research models. These investigations help researchers understand how synthetic copper tripeptide complexes interact with extracellular matrix associated gene expression and cellular signaling systems.
Comparative Multi-Peptide Pathway Research — All Three Compounds Experimental models have explored how peptides from thymosin, pentadecapeptide, and copper tripeptide classification families interact with overlapping and divergent cellular signaling networks in laboratory research settings. These investigations support comparative research into how structurally distinct synthetic peptides from three independent classification families interact with cytoskeletal, growth factor receptor, and extracellular matrix regulatory signaling systems.
Pathway Interaction Overview
Research has examined TB-500 for its interaction with actin-binding pathways involved in cytoskeletal organization, BPC-157 for its interaction with growth factor receptor systems involved in vascular and fibroblast signaling pathways, and GHK-Cu for its interaction with extracellular matrix signaling mechanisms and copper-dependent cellular regulatory pathways in laboratory research models.
Laboratory studies investigate how receptor binding and extracellular interactions for each compound independently influence intracellular signaling mechanisms, including cytoskeletal communication systems for TB-500, growth factor receptor cascades for BPC-157, and extracellular matrix associated gene expression regulatory pathways for GHK-Cu in controlled research settings.
Scientists analyze how pathway activation for each respective compound may influence downstream signaling interactions that regulate cellular activity within their independently documented research pathway contexts, providing researchers with comparative data across three distinct areas of synthetic peptide signaling research.
Literature Overview
Scientific literature surrounding TB-500, BPC-157, and GHK-Cu addresses three distinct areas of peptide receptor interaction and extracellular signaling research, with each compound independently documented across preclinical laboratory investigations spanning multiple decades of published scientific literature.
Key themes explored in laboratory research include:
These investigations help expand scientific understanding of how synthetic peptides from distinct classification families interact with receptor mediated and extracellular signaling systems across multiple cellular regulatory pathway contexts.
References
TB-500 (Thymosin Beta-4)
BPC-157 (Body Protection Compound-157)
GHK-Cu (Glycine-Histidine-Lysine Copper)
Researchers interested in the biochemical and signaling characteristics of TB-500, BPC-157, and GHK-Cu are encouraged to review peer reviewed publications within these scientific databases.
Reviews
There are no reviews yet.
Only logged in customers who have purchased this product may leave a review.